Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux

About this trial

Immunotherapy have revolutionized the field of oncology, but response rates are low and all patients relapse, due to cellular and soluble immunosuppressive mechanisms. MDSC are one of the most important immunosuppressive cells, that also harbour non immunologic functions, favouring cancer invasion. These non immunologic functions of MDSC in lung cancer will be better characterized. Indeed, cellular mechanisms will be analysed by in vitro studies, assessing the effect of immunosuppressive cells, provided by fresh tumor samples, on phenotype and functions of lung cancer cell lines. The aim of this study is to better characterize immunosuppressive landscape of NSCLC and mechanisms involved in their protumor functions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

consecutive patients

lung carcinoma surgically treated by surgery only

Disqualifiers

patient receiving chemotherapy, radiotherapy or immunotherapy in the neoadjuvant setting (all objectives)

patient with concomitant or previous cancer (in the 2 years)

Trial population

Patients with lung carcinoma surgically treated by surgery only

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Tumor samples

    Procedure/Surgery

    Tumor samples will be collected by the pathologist at the reception of the tumor removed during surgery

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: Patients with lung carcinoma surgically treated by surgery only1 intervention

Trial outcomes

Primary outcomes

1

Comparative analysis of the modifications of phenotype and functions of lung cancer cell lines when exposed to MDSC extracted from patient tumor tissue

Functional in vitro studies of the effect of MDSC extracted from resected NSCLC prospectively collected on phenotype and function of lung cancer cell lines

Time frame
At the time of surgery only, when fresh tumor is resected

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: